pharmaphorum

JULY 29, 2021

The use of specialty drugs in the U.S. It’s estimated specialty medications account for 75% of the approximately 7,000 prescription drugs currently in development, and by 2022, more than 60% of the 600 drugs expected to gain FDA approval will be specialty medications.

Pharmacy 110

Pharmacy Drugs FDA Approval Marketing 110

Drug Channels

JULY 20, 2022

In this issue: CVS disassociates itself from its chain pharmacy association Payers are paying attention to ICER Benefits of the biosimilar boom A fantastic takedown of health insurance deductibles Plus, I join the Advisory Board of Alto Pharmacy. d/b/a Drug Channels Institute. P.S. Join my nearly 30,000 (!) to 1:30 p.m.

Pharmacy 83

Pharmacy Drugs Marketing Development 83

BioTech 365

AUGUST 31, 2021

News, Trends, Challenges in Specialty Pharmacy: Rx Drug Manufacturers, Benefits Decision Makers Find Solutions in AscellaHealth Developments in Specialty Pharmacy Newsletter News, Trends, Challenges in Specialty Pharmacy: Rx Drug Manufacturers, Benefits Decision Makers Find Solutions in AscellaHealth Developments in Specialty … Continue reading (..)

Pharmacy 52

Pharmacy Manufacturing Development Drugs 52

Drug Channels

NOVEMBER 15, 2022

The rise of discount card pricing within pharmacy benefit plans is a positive development. However, I suspect few people understand that placing discount cards within the pharmacy benefit enables a PBM to monetize a new fee stream from the card vendor. d/b/a Drug Channels Institute. Links below. to 1:30 p.m. to 1:30 p.m.

Pharmacy 89

Pharmacy Drugs Marketing Generic Drugs 89

ACRP blog

NOVEMBER 8, 2023

As several retail pharmacy chains proclaim a rosy outlook for ongoing efforts to expand their services into the clinical trials arena in the wake of the pandemic, traditional study site personnel and patients interviewed on the topic offered more mixed and nuanced concerns about the prospects for near-term success for such ventures.

Pharmacy 59

Pharmacy Trials Clinical Trials Clinical Trials 59

Drug Channels

MAY 23, 2023

Below, you’ll find Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share based on equivalent prescription claims. I also provide commentary on recent market developments and offer some helpful tips for interpreting the figures. d/b/a Drug Channels Institute. to 1:30 p.m.

Pharmacy 95

Pharmacy Marketing Drugs Development 95

pharmaphorum

JUNE 8, 2022

Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM) companies – the middlemen in the supply chain – are being formally investigated by the Federal Trade Commission (FTC). — FTC (@FTC) June 7, 2022. — FTC (@FTC) June 7, 2022.

Pharmacy 63

Pharmacy Medicine Manufacturing Drugs 63

ACRP blog

NOVEMBER 8, 2023

As several retail pharmacy chains proclaim a rosy outlook for ongoing efforts to expand their services into the clinical trials arena in the wake of the pandemic, traditional study site personnel and patients interviewed on the topic offered more mixed and nuanced concerns about the prospects for near-term success for such ventures.

Pharmacy 52

Pharmacy Trials Clinical Trials Clinical Trials 52

pharmaphorum

JANUARY 4, 2023

Retail pharmacies in the US will be able to dispense mifepristone-based therapies to end pregnancies after the FDA introduced changes to its regulatory framework for the products. Pharmacies will have to apply for certification to dispense mifepristone under the REMS. The updated REMS marks the culmination of that review. .

Pharmacy 87

Pharmacy Sales Production Drugs 87

Drug Channels

MARCH 5, 2024

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s latest live video webinar: Drug Channel Implications of the Inflation Reduction Act This event will be broadcast live on Friday, April 5, 2024, from 12:00 p.m. Pharmacies and Pharmacy Benefit Managers.

Drugs 86

Drugs Pharmacy Marketing Branding 86

FDA Law Blog

AUGUST 21, 2023

Attorney’s Office for the Western District of Texas announced that People’s Rx, a local chain operating five retail pharmacies and a compounding laboratory in the Austin area, agreed to pay $200,000 to settle allegations that it violated the Controlled Substances Act (“CSA”). 16, 2023 ( DOJ Press Release ). 2, 2020 ( DOJ Press Release ).

Pharmacy 52

Pharmacy Regulation Sales Production 52

Outsourcing Pharma

APRIL 19, 2024

LGM Pharma is a leading CDMO provider of comprehensive API sourcing and drug product contract development and manufacturing solutions to the pharmaceutical, biotechnology, and compounding pharmacy industries.

Pharmacy 98

Pharmacy Manufacturing Production Development 98

Pharma Tutor

JULY 13, 2022

A REVIEW ON COMPUTER AIDED DRUG DESIGN (CAAD) AND IT’S IMPLICATIONS IN DRUG DISCOVERY AND DEVELOPMENT PROCESS. 1,2,3,4 Sahyadri College of Pharmacy Methwade Tal, Sangola, Distsolapur Maharashtra 413307. About Authors. Sayyed , Ms. Wed, 07/13/2022 - 15:34. Review Articles.

Development 59

Development Drugs Pharmacy 59

Drug Channels

APRIL 5, 2022

Consider Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share, shown in the chart below. As I explain below, the prospects for market disruption remain low, so the controversial warped incentives of the rebate system will continue to distort the drug channel. Click here for more details.

Pharmacy 95

Pharmacy Marketing Drugs Development 95

Pharmacy Checkers

APRIL 3, 2020

When I read fancy-looking international reports that address the problem of counterfeit drugs, too seldom is our work recognized in verifying international online pharmacies in a manner that saves the lives of consumers looking online for affordable medicine. percent – or $461 billion— of the world drug market in 2013.”

Pharmacy 60

Pharmacy Drugs Medicine Sales 60

World of DTC Marketing

FEBRUARY 21, 2022

Experts across the board are predicting demand for antiviral drugs will rapidly outpace supply. Pfizer and Merck have chosen to designate a select few generic manufacturers to produce cheaper versions of their drugs through the Medicines Patent Pool (MPP). Reportedly, the cost of production for molnupiravir stands at about $17.74.

Regulation 218

Regulation Drugs Bioequivalency Pharmacy 218

STAT News

MARCH 9, 2023

… An experimental Eli Lilly drug failed to prevent memory loss in a study of healthy older people with a high risk of developing clinical Alzheimer’s disease in one of the first studies aimed at stopping symptoms before they start, The Wall Street Journal writes. Continue to STAT+ to read the full story…

Pharmacy 98

Pharmacy Drugs Protein Development 98

Worldwide Clinical Trials

FEBRUARY 21, 2024

During clinical development, new chemical entities (NCEs) require an absorption, metabolism, and excretion (AME) study. Dosing Our pharmacy services can prepare liquid, solid, and intravenous dosage formulations. To accomplish this, we pay careful attention to both dosing and sample collection.

Clinical Trials 201

Clinical Trials Clinical Trials Pharmacy Trials 201

pharmaphorum

DECEMBER 21, 2021

However, despite the work still left to be done, there are now a growing number of treatments in the pipeline and 2020 proved to be a remarkable year for orphan drug approvals, with the US FDA approving more orphan designated treatments than non-orphan drugs. This leads back to the barriers in developing successful treatments.

Development 96

Development Genome Genomics Drugs 96

Drug Channels

JULY 6, 2020

Next week, Drug Channels Institute will release our 2020 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. It’s the 11th edition of our popular and comprehensive examination of the entire drug pricing, reimbursement, and dispensing system. d/b/a Drug Channels Institute.

Pharmacy 52

Pharmacy Drugs Business Development Marketing 52

Drug Channels

JULY 6, 2020

Next week, Drug Channels Institute will release our 2020 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. It’s the 11th edition of our popular and comprehensive examination of the entire drug pricing, reimbursement, and dispensing system. d/b/a Drug Channels Institute.

Pharmacy 52

Pharmacy Drugs Business Development Marketing 52

Pharmaceutical Technology

JANUARY 2, 2023

Danicamtiv is under clinical development by Bristol-Myers Squibb and currently in the Phase I and Phase II in clinical pathway. Danicamtiv overview Danicamtiv (MYK-491, DCM-1) is under development for the treatment of dilated cardiomyopathy (DCM), atrial fibrillation and systolic heart failure.

Drugs 100

Drugs Pharmacy Production Development 100

XTalks

JANUARY 5, 2024

Eli Lilly launched LillyDirect this week, an online service that provides access to the company’s medicines, including its newly approved weight loss drug Zepbound (tirzepatide). Interestingly, the company’s blockbuster diabetes drug, Mounjaro (tirzepatide), is not available through the new digital service.

Drugs 59

Drugs Pharmacy Cosmetics Insulin 59

Drug Discovery World

SEPTEMBER 6, 2023

The funding will support the development of the company’s gene therapy in a powder, a non-viral gene delivery system to improve tissue regeneration following surgery. The post Innovate UK grant to support development of powdered gene therapy appeared first on Drug Discovery World (DDW).

Gene Therapy 52

Gene Therapy Gene Development Drug Delivery 52

pharmaphorum

JUNE 6, 2022

American entrepreneur and investor Mark Cuban tells us why he and his partners launched the Mark Cuban Cost Plus Drug Company (MCCPDC), a public-benefit corporation and online pharmacy that provides patients access to medications at a lower cost. . “Manufacturers get a bad rap as being the source of high pricing for patient meds.

Drugs 144

Drugs Manufacturing Pharmacy Branding 144

FDA Law Blog

JUNE 3, 2021

Schlanger — While federal efforts to address prescription drug prices are debated, states have continued to pursue their own measures that require drug manufacturers and other entities in the drug supply chain to disclose information about pricing. A summary of these new state law developments is included below.

Development 52

Development Drugs Manufacturing Pharmacy 52

Pharmaceutical Technology

SEPTEMBER 7, 2022

Pharmaceutical benefit managers and management companies serve as intermediaries between insurance companies, pharmacies, and drug manufacturers. They bring together employers/plan sponsors, health insurers, plan members, drug wholesalers, pharmacies, and drug companies to facilitate better health outcomes at an affordable cost.

Pharmacy 130

Pharmacy Containment Manufacturing Compliance 130

Drug Channels

SEPTEMBER 18, 2020

Today’s guest post comes from Ela Lourido, Vice President of Business Development at Biologics by Mckesson. Ela discusses the important role independent specialty pharmacies play in educating payers, supporting patients, and ultimately getting potentially life-saving therapies into the hands of patients. d/b/a Drug Channels Institute.

Pharmacy 40

Pharmacy Drugs Business Development Manufacturing 40

Pharmaceutical Technology

JULY 20, 2022

On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. Previously, only licensed and authorised physicians, advanced practice registered nurses, and physician assistants could prescribe the drug. .

Pharmacy 278

Pharmacy Licensing Licensing Drugs 278

Pharma Mirror

NOVEMBER 21, 2020

Medisafe, a leading digital therapeutics company specializing in digital companions, has been selected by UCB to develop branded digital drug companions for its antiepileptic medications, with greater capabilities to expand across additional brands. 1 in 26 people in the US will develop epilepsy at some point in their.

Development 130

Development Branding Doctors Doctor 130

Pharmaceutical Technology

JULY 14, 2022

The commercial investment required to research and develop an innovative drug, prove its safety and efficacy, and bring it to market is staggering. Most famously, the US passed its Orphan Drug Act in 1983, providing innovators with financial motivation to develop orphan drugs and meet the needs of these forgotten patients.

Drugs 147

Drugs Medicine Marketing Development 147

FDA Law Blog

MAY 31, 2021

Kirschenbaum — The past two weeks have seen two noteworthy developments relating to CMS’s Medicaid Drug Rebate Program (MDRP) regulations. Manufacturers provide patient savings programs at the pharmacy counter to defray the patient’s out-of-pocket costs such as co-pays and deductibles. By Faraz Siddiqui & Alan M.

Development 52

Development Drugs Manufacturing Regulation 52

Pharma Mirror

APRIL 18, 2023

Dudley, UK, April 18th 2023: Sterling Pharma Solutions, a global contract development and manufacturing organisation, today announced that it has been granted a Manufacturer’s Authorisation for Investigational Medicinal Products from the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA).

Licensing 130

Licensing Licensing Manufacturing Antibody 130

Pharmaceutical Technology

MAY 15, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Oxazole derivatives-based cancer drug compositions. Hoffmann-La Roche is the leading patent filer of oxazole derivatives-based cancer drug compositions.

Drugs 130

Drugs DNA Protein Antibody 130

The Pharma Data

SEPTEMBER 25, 2020

British consumers have increasingly turned to community pharmacies during the coronavirus pandemic, according to a new study. Carlton Lawson, Area Managing Director for Northern Europe at Johnson & Johnson Consumer Health, said: “The role of community pharmacy has never been more important.

Pharmacy 52

Pharmacy Production Doctors Doctor 52

STAT News

MARCH 10, 2023

Enjoy, and see you soon … By law, Medicare will have to take a medication’s efficacy and its research and development costs into account when it starts to negotiate drug prices — but recent research shows pharma companies ignore those factors when they pick prices for their products , STAT explains. Two

Insulin 96

Insulin Pharmacy Pharma Companies Production 96

Pharmaceutical Technology

MARCH 10, 2023

The US Food and Drug Administration (FDA) has granted approval for Pfizer ’s Zavzpret (zavegepant) for the acute treatment of migraine in adult patients with or without aura. The company expects to launch Zavzpret in pharmacies in July.

FDA Approval 246

FDA Approval Pharmacy Trials Clinical Development 246